Published in Regul Toxicol Pharmacol on April 03, 2011
Evaluation of biomonitoring data from the CDC National Exposure Report in a risk assessment context: perspectives across chemicals. Environ Health Perspect (2012) 1.04
Human exposure to soil contaminants in subarctic Ontario, Canada. Int J Circumpolar Health (2015) 0.75
Evaluation of physiologically based pharmacokinetic models for use in risk assessment. J Appl Toxicol (2007) 1.94
An evaluation of benchmark dose methodology for non-cancer continuous-data health effects in animals due to exposures to dioxin (TCDD). Regul Toxicol Pharmacol (2004) 1.72
Dioxin risks in perspective: past, present, and future. Regul Toxicol Pharmacol (2003) 1.61
Mortality rates among trichlorophenol workers with exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Am J Epidemiol (2009) 1.53
Deriving uncertainty factors for threshold chemical contaminants in drinking water. J Toxicol Environ Health B Crit Rev (2007) 1.44
Concentration-dependent TCDD elimination kinetics in humans: toxicokinetic modeling for moderately to highly exposed adults from Seveso, Italy, and Vienna, Austria, and impact on dose estimates for the NIOSH cohort. J Expo Anal Environ Epidemiol (2005) 1.26
Incorporating new technologies into toxicity testing and risk assessment: moving from 21st century vision to a data-driven framework. Toxicol Sci (2013) 1.10
Sources of variability in biomarker concentrations. J Toxicol Environ Health B Crit Rev (2014) 1.09
Evaluation of biomonitoring data from the CDC National Exposure Report in a risk assessment context: perspectives across chemicals. Environ Health Perspect (2012) 1.04
Human response to dioxin: aryl hydrocarbon receptor (AhR) molecular structure, function, and dose-response data for enzyme induction indicate an impaired human AhR. J Toxicol Environ Health B Crit Rev (2006) 1.04
A method to integrate benchmark dose estimates with genomic data to assess the functional effects of chemical exposure. Toxicol Sci (2007) 1.00
Analysis of manganese tracer kinetics and target tissue dosimetry in monkeys and humans with multi-route physiologically based pharmacokinetic models. Toxicol Sci (2010) 0.99
Cholinesterase inhibition in chlorpyrifos workers: Characterization of biomarkers of exposure and response in relation to urinary TCPy. J Expo Sci Environ Epidemiol (2008) 0.99
Temporal trends in human TCDD body burden: decreases over three decades and implications for exposure levels. J Expo Anal Environ Epidemiol (2002) 0.96
A unified algorithm for predicting partition coefficients for PBPK modeling of drugs and environmental chemicals. Toxicol Appl Pharmacol (2010) 0.95
Variation in urinary flow rates according to demographic characteristics and body mass index in NHANES: potential confounding of associations between health outcomes and urinary biomarker concentrations. Environ Health Perspect (2015) 0.95
Environmental chemicals in people: challenges in interpreting biomonitoring information. J Environ Health (2008) 0.94
Public health interpretation of trihalomethane blood levels in the United States: NHANES 1999-2004. J Expo Sci Environ Epidemiol (2009) 0.94
Naphthalene metabolism in relation to target tissue anatomy, physiology, cytotoxicity and tumorigenic mechanism of action. Regul Toxicol Pharmacol (2007) 0.93
Physiologically based pharmacokinetic modeling of fetal and neonatal manganese exposure in humans: describing manganese homeostasis during development. Toxicol Sci (2011) 0.92
Physiological modeling of age-specific changes in the pharmacokinetics of organic chemicals in children. J Toxicol Environ Health A (2003) 0.92
Human biomonitoring assessment values: approaches and data requirements. Int J Hyg Environ Health (2011) 0.92
Guidelines for the derivation of Biomonitoring Equivalents: report from the Biomonitoring Equivalents Expert Workshop. Regul Toxicol Pharmacol (2008) 0.91
Guidelines for the communication of Biomonitoring Equivalents: report from the Biomonitoring Equivalents Expert Workshop. Regul Toxicol Pharmacol (2008) 0.91
Approaches for applications of physiologically based pharmacokinetic models in risk assessment. J Toxicol Environ Health B Crit Rev (2008) 0.90
Physiologically based modeling of the accumulation in plasma and tissue lipids of a mixture of PCB congeners in female Sprague-Dawley rats. J Toxicol Environ Health A (2005) 0.90
Interpreting variability in population biomonitoring data: role of elimination kinetics. J Expo Sci Environ Epidemiol (2012) 0.90
Derivation of Biomonitoring Equivalents for di-n-butyl phthalate (DBP), benzylbutyl phthalate (BzBP), and diethyl phthalate (DEP). Regul Toxicol Pharmacol (2009) 0.89
Database for physiologically based pharmacokinetic (PBPK) modeling: physiological data for healthy and health-impaired elderly. J Toxicol Environ Health B Crit Rev (2009) 0.88
Quantitative structure-property relationships for physiologically based pharmacokinetic modeling of volatile organic chemicals in rats. Toxicol Appl Pharmacol (2003) 0.88
Biomonitoring Equivalents for bisphenol A (BPA). Regul Toxicol Pharmacol (2010) 0.87
Mortality in workers exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin at a trichlorophenol plant in New Zealand. J Occup Environ Med (2009) 0.86
Perspective on serum dioxin levels in the United States: an evaluation of the NHANES data. J Expo Sci Environ Epidemiol (2008) 0.86
Physiologically-based pharmacokinetic (PBPK) models in toxicity testing and risk assessment. Adv Exp Med Biol (2012) 0.86
Chemical-specific screening criteria for interpretation of biomonitoring data for volatile organic compounds (VOCs)--application of steady-state PBPK model solutions. Regul Toxicol Pharmacol (2010) 0.86
Consideration of dosimetry in evaluation of ToxCast™ data. J Appl Toxicol (2011) 0.85
Equilibrium unfolding of neuronal calcium sensor-1: N-terminal myristoylation influences unfolding and reduces protein stiffening in the presence of calcium. J Biol Chem (2005) 0.85
Evaluating placental transfer and tissue concentrations of manganese in the pregnant rat and fetuses after inhalation exposures with a PBPK model. Toxicol Sci (2009) 0.85
A chronic oral reference dose for hexavalent chromium-induced intestinal cancer. J Appl Toxicol (2013) 0.85
A mechanism-based cancer risk assessment for 1,4-dichlorobenzene. Regul Toxicol Pharmacol (2007) 0.84
Multi-dose-route, multi-species pharmacokinetic models for manganese and their use in risk assessment. J Toxicol Environ Health A (2010) 0.84
Quantitative structure-property relationships for interspecies extrapolation of the inhalation pharmacokinetics of organic chemicals. Chem Res Toxicol (2005) 0.83
Using Biomonitoring Equivalents to interpret human biomonitoring data in a public health risk context. J Appl Toxicol (2009) 0.83
Derivation of Biomonitoring Equivalents for di(2-ethylhexyl)phthalate (CAS No. 117-81-7). Regul Toxicol Pharmacol (2009) 0.82
Human biomonitoring as a pragmatic tool to support health risk management of chemicals--examples under the EU REACH programme. Regul Toxicol Pharmacol (2010) 0.82
Urinary DEHP metabolites and fasting time in NHANES. J Expo Sci Environ Epidemiol (2011) 0.82
Biomonitoring-based risk assessment for hexabromocyclododecane (HBCD). Int J Hyg Environ Health (2011) 0.82
Mortality rates among workers exposed to dioxins in the manufacture of pentachlorophenol. J Occup Environ Med (2009) 0.81
Hexavalent chromium reduction kinetics in rodent stomach contents. Chemosphere (2012) 0.81
Biomonitoring Equivalents (BE) dossier for acrylamide (AA) (CAS No. 79-06-1). Regul Toxicol Pharmacol (2008) 0.81
Biomonitoring Equivalents (BE) dossier for 2,4-dichlorophenoxyacetic acid (2,4-D) (CAS No. 94-75-7). Regul Toxicol Pharmacol (2008) 0.81
Biomonitoring Equivalents (BE) dossier for cadmium (Cd) (CAS No. 7440-43-9). Regul Toxicol Pharmacol (2008) 0.81
Biomonitoring equivalents for di-isononyl phthalate (DINP). Regul Toxicol Pharmacol (2011) 0.81
Derivation of physiological inhalation rates in children, adults, and elderly based on nighttime and daytime respiratory parameters. Inhal Toxicol (2011) 0.81
Toxicokinetics and physiologically based toxicokinetics in toxicology and risk assessment. J Toxicol Environ Health B Crit Rev (2003) 0.80
Biomonitoring Equivalents for benzene. Regul Toxicol Pharmacol (2011) 0.80
Is age an independent risk factor for chemically induced acute myelogenous leukemia in children? J Toxicol Environ Health B Crit Rev (2007) 0.80
Interpreting human biomonitoring data in a public health risk context using Biomonitoring Equivalents. Int J Hyg Environ Health (2011) 0.80
Lactational transfer of manganese in rats: predicting manganese tissue concentration in the dam and pups from inhalation exposure with a pharmacokinetic model. Toxicol Sci (2009) 0.80
Biomonitoring equivalents for inorganic arsenic. Regul Toxicol Pharmacol (2010) 0.80
Toxicokinetics of 2,3,7,8-TCDF and 2,3,4,7,8-PeCDF in mink (Mustela vison) at ecologically relevant exposures. Toxicol Sci (2008) 0.80
Pharmacokinetic modeling of manganese. II. Hepatic processing after ingestion and inhalation. J Toxicol Environ Health A (2007) 0.80
A tool for rapid screening of direct DNA agents using reaction rates and relative interaction potency: towards screening environmental contaminants for hazard. J Environ Monit (2011) 0.80
Biomonitoring Equivalents for triclosan. Regul Toxicol Pharmacol (2010) 0.80
Potential of fluorescence imaging techniques to monitor mutagenic PAH uptake by microalga. Environ Sci Technol (2014) 0.80
Persistent organic pollutants in matched breast milk and infant faeces samples. Chemosphere (2015) 0.79
Tissue distribution of dioxin-like compounds: potential impacts on systemic relative potency estimates. Toxicol Lett (2013) 0.79
Pharmacokinetic modeling of manganese. III. Physiological approaches accounting for background and tracer kinetics. J Toxicol Environ Health A (2007) 0.79
Biomonitoring equivalents for hexachlorobenzene. Regul Toxicol Pharmacol (2010) 0.79
Triose phosphate isomerase, a novel enzyme-crystallin, and tau-crystallin in crocodile cornea. High accumulation of both proteins during late embryonic development. FEBS J (2006) 0.79
Biomonitoring equivalents for 2,2',4,4',5-pentabromodiphenylether (PBDE-99). Regul Toxicol Pharmacol (2011) 0.79
Evaluation of NHANES biomonitoring data for volatile organic chemicals in blood: application of chemical-specific screening criteria. J Expo Sci Environ Epidemiol (2011) 0.79
Biomonitoring equivalents for deltamethrin. Regul Toxicol Pharmacol (2011) 0.78